Investor & Analyst Update | New York, USA

Innate Pharma's management team gave an overview of the Company's pipeline of first-in-class monoclonal antibodies in Immuno-Oncology and provided an update on the Company's strategy.

A webcast replay is accessible at http://urlz.fr/3xlM

Click here to download the slideshow

 

Date